Physician profile
Alexander E Voldman
NPI 1659622900
$7,282.37
in general payments reported to CMS, 2019-2025
23 companies · $2,462 in 2025
The $2,462 reported for 2025 was more than what 90% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,061 · 2020: $137 · 2021: $97.95 · 2022: $480 · 2023: $786 · 2024: $2,259 · 2025: $2,462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,500 · Food and Beverage: $1,989 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,500.00 |
| Food and Beverage | $1,989.02 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $5,036.16 | 2019-2025 | Lensx, Argos, Clareon |
| Sight Sciences, INC. | $433.10 | 2020-2024 | Omni Surgical System |
| Glaukos Corporation | $203.83 | 2025 | Idosetr |
| Tarsus Pharmaceuticals, INC. | $196.59 | 2024-2025 | Xdemvy |
| Carl Zeiss Meditec Cataract Technology INC. | $192.37 | 2023 | |
| Johnson & Johnson Surgical Vision, INC. | $191.17 | 2022-2024 | Tecnis Simplicity |
| Allergan, INC. | $145.16 | 2019-2022 | |
| Shire North American Group INC | $144.50 | 2019 | |
| Omeros Corporation | $118.37 | 2019 | |
| Dompe US, INC. | $111.66 | 2019-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $86.19 | 2019 | |
| Regeneron Pharmaceuticals, INC. | $86.05 | 2019 | |
| Bausch & Lomb Americas INC. | $60.43 | 2022-2023 | Envista Mx60 Iol, Miebo |
| Novartis Pharmaceuticals Corporation | $57.07 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $43.35 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $37.20 | 2024-2025 | Iheezo, Vevye |
| Rayner Intraocular Lenses Limited | $26.83 | 2024 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| Abbvie INC. | $23.81 | 2022 | |
| Rxsight INC | $23.47 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Horizon Therapeutics Plc | $20.69 | 2023 | Tepezza |
| Eyevance Pharmaceuticals LLC | $17.53 | 2019 | |
| Ocular Therapeutix, INC. | $13.95 | 2024 | Dextenza |
| Oyster Point Pharma, INC. | $12.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Voldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.